Delivery Order SPE2DB22D3301-SPE2DB25FX7GV

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7GV
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $19,019.54 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,760 units of 4 mg Ondansetron HCl tablets. This Delivery Order falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This contract does not have a set-aside designation, indicating open competition. The products procured under this contract support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply programs.

Generated 3/19/25, 9:44 AM